CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Inventory Write-down
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Inventory Write-down of $3.17 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for the quarter ending 2026-06-27 was $1.68M, a 61.07% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for the quarter ending 2026-03-28 was $1.49M, a 77.98% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for the quarter ending 2025-12-27 was $1.75M, a 93.53% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for the quarter ending 2025-09-27 was -$370.00K, a 104.58% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for fiscal 2025 was $12.44M, a 73.52% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for fiscal 2024 was $46.99M, a 647.09% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for fiscal 2023 was $6.29M, a 5.31% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. inventory write-down for fiscal 2022 was $5.97M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-27 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.17M 10-Q · filed 2026-08-05 | $4.91M derived: sum of 3 quarters · filed 2026-08-05 | $4.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $1.49M 10-Q · filed 2026-05-07 | $3.24M derived: sum of 2 quarters · filed 2026-05-07 | $2.87M derived: sum of 3 quarters · filed 2026-05-07 | $7.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-27 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.38M derived: sum of 2 quarters · filed 2026-02-18 | $5.68M derived: sum of 3 quarters · filed 2026-08-05 | $12.44M 10-K · filed 2026-02-18 |
| 2025-09-27 | -$370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.94M derived: sum of 2 quarters · filed 2026-08-05 | $10.70M 10-Q · filed 2025-11-05 | $37.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.07M 10-Q · filed 2026-08-05 | $38.07M derived: sum of 3 quarters · filed 2026-08-05 | $46.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $6.76M 10-Q · filed 2026-05-07 | $33.76M derived: sum of 2 quarters · filed 2026-05-07 | $41.84M derived: sum of 3 quarters · filed 2026-05-07 | $43.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-28 | $27.00M 10-K · filed 2026-02-18 | $35.08M derived: sum of 2 quarters · filed 2026-02-18 | $36.68M derived: sum of 3 quarters · filed 2026-02-18 | $46.99M 10-K · filed 2026-02-18 |
| 2024-09-28 | $8.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.68M derived: sum of 2 quarters · filed 2025-11-05 | $11.47M 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.40M 10-Q · filed 2025-08-06 | ||
| 2024-03-30 | $1.79M 10-Q · filed 2025-05-07 | |||
| 2023-12-30 | $6.29M 10-K · filed 2026-02-18 | |||
| 2022-12-31 | $5.97M 10-K · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |